Quest Diagnostics (DGX) Payables (2009 - 2026)

Quest Diagnostics has reported Payables for 18 years, with the latest figure at $1.6 billion in Q2 2026.

• Quarterly Payables rose 18.46% year-over-year to $1.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (up 18.46% YoY) and the FY2025 annual result came in at $1.6 billion, up 14.78% from the prior year.
• Payables climbed to $1.6 billion in Q2 2026 per DGX's latest filing, from $1.5 billion in the prior quarter.
• Over five years, Payables peaked at $1.6 billion in Q4 2025 and troughed at $1.2 billion in Q3 2023.
• A 5-year average of $1.4 billion and a median of $1.4 billion in 2023 frame the typical range for Payables.
• The sharpest annual moves came in 2023 and 2026: Payables decreased 22.41% in 2023, then grew 18.46% in 2026.
• Over 5 years, Payables stood at $1.4 billion in 2022, then slipped by 2.65% to $1.4 billion in 2023, then grew by 2.58% to $1.4 billion in 2024, then increased by 14.78% to $1.6 billion in 2025, then dropped by 0.12% to $1.6 billion in 2026.
• According to Business Quant data, Payables over the past three periods registered $1.6 billion, $1.5 billion, and $1.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.